BioPharmGuy logo
Sponsored By:
Trianni Inc.
BioPharmGuy Database
Emery Pharma
Genable Technologies is defunct.

Fate: Bought by Spark Therapeutics, March 2016, $15M


------------------
If you believe any of this information is incorrect, please let us know.